Mar 24, 2022 / 08:30PM GMT
Operator
Good afternoon, ladies and gentlemen, and welcome to the TFF Pharmaceuticals Fourth Quarter and Year-End 2021 Financial Results Conference Call. As a reminder, this conference is being recorded.
I would now like to turn the call over to your host, Corey Davis of LifeSci Advisors. You may begin your conference at this time.
Corey George Davis - LifeSci Advisors, LLC - Relationship Manager
Thank you, operator. Hello, everyone, and welcome to the TFF Pharmaceuticals fourth quarter and year-end '21 financial and business results conference call. With me on the line today is Glenn Mattes, President and CEO of TFF, Kirk Coleman, Chief Financial Officer; Dr. Dale Christensen, TFF Director of Clinical Development; Dr. Bill Williams in the University of Texas and Austin; and Chris Cano, TFF's Chief Operating Officer.
The press release announcing our fourth quarter results is available on the TFF Pharmaceuticals website. Please take a moment to read the disclaimer about forward-looking statements in the press release.
The earnings release and
Q4 2021 TFF Pharmaceuticals Inc Earnings Call Transcript
Mar 25, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers